Function and genetics of dystrophin and dystrophin-related proteins in muscle

DJ Blake, A Weir, SE Newey… - Physiological …, 2002 - journals.physiology.org
The X-linked muscle-wasting disease Duchenne muscular dystrophy is caused by mutations
in the gene encoding dystrophin. There is currently no effective treatment for the disease; …

The pathogenesis and therapy of muscular dystrophies

S Guiraud, A Aartsma-Rus, NM Vieira… - Annual review of …, 2015 - annualreviews.org
Current molecular genomic approaches to human genetic disorders have led to an
explosion in the identification of the genes and their encoded proteins responsible for these …

[PDF][PDF] Mechanisms of muscle injury, repair, and regeneration

JG Tidball - Comprehensive physiology, 2011 - drive.google.com
Skeletal muscle continuously adapts to changes in its mechanical environment through
modifications in gene expression and protein stability that affect its physiological function …

Muscle spindle function in healthy and diseased muscle

S Kröger, B Watkins - Skeletal Muscle, 2021 - Springer
Almost every muscle contains muscle spindles. These delicate sensory receptors inform the
central nervous system (CNS) about changes in the length of individual muscles and the …

Expression of full-length utrophin prevents muscular dystrophy in mdx mice

J Tinsley, N Deconinck, R Fisher, D Kahn, S Phelps… - Nature medicine, 1998 - nature.com
Duchenne muscular dystrophy (DMD) is a lethal, progressive muscle wasting disease
caused by a loss of sarcolemmal bound dystrophin, which results in the death of the muscle …

Skeletal and cardiac myopathies in mice lacking utrophin and dystrophin: a model for Duchenne muscular dystrophy

RM Grady, H Teng, MC Nichol, JC Cunningham… - Cell, 1997 - cell.com
Dystrophin is a cytoskeletal protein of muscle fibers; its loss in humans leads to Duchenne
muscular dystrophy, an inevitably fatal wasting of skeletal and cardiac muscle. mdx mice …

[HTML][HTML] Pharmacological advances for treatment in Duchenne muscular dystrophy

S Guiraud, KE Davies - Current opinion in pharmacology, 2017 - Elsevier
Highlights•Numerous pathophysiological features of DMD provide different therapeutic
avenues.•Pharmacolougical therapies target all muscles and are applicable to all DMD …

[HTML][HTML] Immunobiology of inherited muscular dystrophies

JG Tidball, SS Welc… - Comprehensive …, 2018 - ncbi.nlm.nih.gov
The immune response to acute muscle damage is important for normal repair. However, in
chronic diseases such as many muscular dystrophies, the immune response can amplify …

Muscle and cardiac therapeutic strategies for Duchenne muscular dystrophy: past, present, and future

A Łoboda, J Dulak - Pharmacological Reports, 2020 - Springer
Background Duchenne muscular dystrophy (DMD) is a severe X-linked neuromuscular
childhood disorder that causes progressive muscle weakness and degeneration and results …

Cellular and subcellular localization of the ARPKD protein; fibrocystin is expressed on primary cilia

CJ Ward, D Yuan, TV Masyuk, X Wang… - Human molecular …, 2003 - academic.oup.com
Autosomal recessive polycystic kidney disease (ARPKD) is an infantile form of PKD
characterized by fusiform dilation of collecting ducts and congenital hepatic fibrosis. The …